TY - JOUR
T1 - European society of gynecological oncology task force for fertility preservation
T2 - Clinical recommendations for fertility-sparing management in young endometrial cancer patients
AU - Rodolakis, Alexandros
AU - Biliatis, Ioannis
AU - Morice, Philippe
AU - Reed, Nick
AU - Mangler, Mandy
AU - Kesic, Vesna
AU - Denschlag, Dominik
N1 - Publisher Copyright:
© 2015 by IGCS and ESGO.
PY - 2015/9/5
Y1 - 2015/9/5
N2 - Endometrial cancer (EC) in young women of reproductive age is a relatively rare diagnosis. However, since in the modern era women delay their childbearing for a variety of social reasons, more and more women in the near future will be nulliparous and have a diagnosis of EC at the same time. Hence, a more conservative approach of EC is desirable to preserve fertility of these women, without compromising their survival. Recently, the number of studies reporting encouraging results on fertility-sparing management of EC with high dose of progestins is increasing. It seems that preserving the uterus and the ovaries in a carefully selected patient with EC confers only a very small risk combined with an enormous benefit. Selection of women suitable for such a conservative approach, as well as method of treatment, follow-up, recurrence, obstetric outcomes, and survival rates are very important parameters when consulting women with EC wishing to preserve their fertility. In this article, we try to elucidate all the previously mentioned aspects and formulate clinical recommendations, based on published data, about the most proper approach and consultation of these patients.
AB - Endometrial cancer (EC) in young women of reproductive age is a relatively rare diagnosis. However, since in the modern era women delay their childbearing for a variety of social reasons, more and more women in the near future will be nulliparous and have a diagnosis of EC at the same time. Hence, a more conservative approach of EC is desirable to preserve fertility of these women, without compromising their survival. Recently, the number of studies reporting encouraging results on fertility-sparing management of EC with high dose of progestins is increasing. It seems that preserving the uterus and the ovaries in a carefully selected patient with EC confers only a very small risk combined with an enormous benefit. Selection of women suitable for such a conservative approach, as well as method of treatment, follow-up, recurrence, obstetric outcomes, and survival rates are very important parameters when consulting women with EC wishing to preserve their fertility. In this article, we try to elucidate all the previously mentioned aspects and formulate clinical recommendations, based on published data, about the most proper approach and consultation of these patients.
KW - Endometrial cancer
KW - Fertility sparing
KW - Obstetric outcomes
KW - Progestins
KW - Recurrence
UR - http://www.scopus.com/inward/record.url?scp=84940930055&partnerID=8YFLogxK
U2 - 10.1097/IGC.0000000000000493
DO - 10.1097/IGC.0000000000000493
M3 - Review article
C2 - 26186070
AN - SCOPUS:84940930055
SN - 1048-891X
VL - 25
SP - 1258
EP - 1265
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 7
ER -